Company USA
- core technology is based on the characteristic properties of extremely small, coated superparamagnetic iron oxide nanoparticles. - core competencies include the ability to design such nanoparticles for particular applications, to manufacture the nanoparticles in controlled sizes and to cover the nanoparticles with different coatings depending upon the application for which they will be used. - technology and expertise enable us to synthesize, sterilize and stabilize these iron oxide nanoparticles in a manner necessary for use in pharmaceutical products such as iron replacement therapeutics and magnetic resonance imaging (MRI) contrast agents.
Technology Platform
- iron oxide nanoparticles are composed of bioavailable iron that is easily absorbed by the body and incorporated into the body's iron stores. - As a result, products using core technology are well suited for use in intravenous (IV) iron replacement therapy. - Additionally, the superparamagnetic characteristic of products results in nanoparticles that become strongly magnetic when placed in a magnetic field, but lose their magnetism once the field is removed. - Therefore, use of nanoparticles results in magnetic resonance images that increase the information available to the reviewing physicians. |
||
| CLICK HERE If you would like to receive contact details for this technology provider or ask a question (s) |
|
Privacy Statement | Terms of Use
T: +44 (0) 1786 474768 E: info@nanoposts.com |
|||||